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Background/aim: It is very important for the efficient use of limited capacity and the success of treatment to predict patients who
may need ICU with high mortality rate in the Covid-19 outbreak. In our study, it was aimed to investigate the value of the radiological
involvement on initial CT in demonstrating the ICU transfer and mortality rate of patients.
Materials and methods: All PCR-positive patients were included in the study, whose CT, PCR, and laboratory values were obtained
simultaneously at the time of first admission. Patients were divided into 4 groups in terms of the extent of radiological lesions. These
groups were compared in terms of intensive care transfer needs and Covid-related mortality rates.
Results: A total of 477 patients were included in the study. Ninety of them were group 0 (no lung involvement), 162 were group 1
(mild lesion), 89 were group 2 (moderate lesion), and 136 were group 3 (severe lung involvement). A significant relationship was found
between the extensiveness of the radiological lesion on CT and admission to intensive care and mortality rate. As the initial radiological
involvement amounts increased, the rate of ICU transfer and mortality increased. The mortality rates of the groups were 0%, 3%, 12.3%,
and 12.5%, respectively, and the difference was significant (p < 0.001). Similarly, the ICU transfer rates of the groups were 2.2%, 5.6%,
13.5%, and 17.7%, respectively, and the difference was significant (p < 0.001).
Conclusion: In conclusion, in our study, the strong relationship between the initial radiological extent assessment and the need for
intensive care and mortality rates has been demonstrated, and we believe that our results will make a significant contribution to increase
the success of the health system in predicting patients who may progress, helping clinicians and managing pandemics.
Key words: Covid-19, extensiveness of radiological lesions, intensive care, mortality rate

1. Introduction
While the majority of coronavirus disease 2019 (Covid-19)
patients recover with asymptomatic or mild symptoms,
some of them can progress rapidly to severe respiratory
failure and end-organ failure. It is not possible to predict
which patients will have a severe course and which patients
will need intensive care transfer. We currently have
advanced age, comorbid conditions, and some laboratory
parameters as predictors of severe disease [1,2]. The most
important criteria in determining the need for intensive

care transfer are decrease in saturation, radiological
progression, and increase in C-reactive protein (CRP),
lactate dehydrogenase (LDH), ferritin, and D-dimer
values in the follow-up of patients. However, sometimes
this condition progresses to an irreversible stage, and
patients are lost with macrophage activation syndrome
and excessive inflammatory response [3,4]. Therefore,
before these laboratory parameters and saturation values
deteriorate, it is very valuable to predict patients who
may progress at an earlier stage. In addition, intensive
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care capacities have been exceeded considerably in many
countries during the pandemic and this continues to be
a problem in triage management. Any method that may
help predict which patients are associated with a higher
mortality and require ICU care may improve patient care
and utilization of the capacity [3]. It may also result in
improved patient outcomes by providing early access to
advanced supportive care, such as high flow oxygen therapy,
noninvasive mechanical ventilators, and antiinflammatory
and anticytokine therapy.
Covid-19 frequently involves the lungs and causes viral
pneumonia. Computerized tomography (CT) of the chest
is quite sensitive in identifying viral pneumonia [5]. As the
sensitivity of the real-time reverse transcriptase polymerase
chain reaction (PCR) method, the gold standard in
diagnosing Covid-19, falls short of expectations, chest CT
scans have been extensively used for the early diagnosis
and in treatment decisions [6,7].
The aim of this study was to investigate the value of
thoracic computed tomography performed simultaneously
with PCR positivity and at the time of initial presentation
in predicting disease progression and ICU transfer rate.
For this purpose, in patients with definite diagnosis of
Covid-19, extent of initial radiological involvement degree
was grouped (as no lesion, mild, moderate, and severe
involvement) and the relationship between the groups and
certain laboratory parameters, ICU transfer, and mortality
rates was examined.
2. Materials and methods
This study was conducted retrospectively between 14
March and 4 May in the 3rd stage Education and Research
Hospital, which is the only pandemic center in a city with
a population of 1 million. Only patients who had a CT
scan and certain laboratory examinations on the same day
with Covid-19 specific PCR positivity were included in
the study. (All of the PCR, CT, and laboratory parameters
used in the study belong to the first admission day). Thus,
it was investigated whether the data obtained on the first
day could be a marker for the progression of the disease in
the future.
Patients who were PCR-negative but clinically
Covid-19–compatible, and those with different PCR
positivity and CT/blood analysis days were excluded from
the study. Additionally, since alanine aminotransferase
(ALT), creatine kinase (CK), CRP, LDH, lactate, D-dimer,
ferritin, erythrocyte sedimentation rate (ESR), white
blood cell (WBC), hemoglobulin (Hg), lymphocyte, and
platelet (PLT) values are evaluated for study, patients
with hematological disorders, active liver disease, or
malignancies that could potentially adversely affect the
values of the determined blood parameters were excluded.
Thoracic CT images taken on the same day with
PCR were evaluated by the same radiologist to eliminate

interobserver differences. The chest CT scans were
reviewed by the experienced and blind radiologist for signs
of viral pneumonia, including ground-glass opacities,
consolidation, and presence of nodules. In addition,
lung segments with lesions were detected. Patients were
categorized according to the extent of the lesions. Patients
with no lesions associated with viral pneumonia were
assigned to group 0, those with unilateral and minimal
lesions confined to one segment or lobe were assigned
to group 1 (Figure 1A), patients with less than 3 lesions
that involve multiple lobes or segments were assigned to
group 2 (Figure 1B), and patients with diffuse and bilateral
lesions were assigned to group 3 (Figure 1C). Sample
images of radiographic findings for each group are shown
in Figure 1.
All patients included in the study were followed for
2 months. During this period, patients whose general
condition worsened and who were transferred to intensive
care and died due to Covid-19, despite the standard
treatment and care performed according to the national
guideline were recorded. ICU transfer rates, mortality
rates, and the laboratory values on the first admission day
of the four groups were compared. Thus, the relationship
between the prevalence and extensiveness of Covid-19
lesions in thorax CT at the time of admission and Covid-19
progression was evaluated.
2.1. Statistical analysis
Descriptive statistics were presented as numbers and
percentages for categorical variables and as standard
deviations, minimum and median value for numerical
data. Chi-square test was used to compare paired groups
containing categorical data. Normality was evaluated with
the Shapiro–Wilk test. The Mann–Whitney U test was
used for numerical variables that did not show normal
distribution. The Kruskal–Wallis test was utilized to
compare the numerical data of three or more nonnormally
distributed independent groups. p < 0.05 was considered
statistically significant. SPSS v 20.0 (IBM SPSS Statistics
for Windows, Version 20.0; Armonk, NY, USA) package
program was used for analyses.
3. Results
The 477 patients with a PCR-confirmed diagnosis were
included in this study. The mean patient age was 49.2
years, and 262 (54.9%) patients were male. Fifty-seven of
the patients (11.9%) were asymptomatic. The average time
until the first admissions was 1.43 days, and 387 patients
had lesions consistent with Covid-19 on their chest CT
scans (81.1%). Forty-seven patients (9.8%) were admitted
to the ICU. Thirty-three patients (6.9%) died. Patient
demographics, symptom durations, laboratory test results,
and radiographic findings are shown in Table 1.
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Figure 1. A: Group 1 patients, unilateral lesions limited to a minimal segment or lobe. B: Group 2 patients, including several lobes or
segments but fewer than 3 lesions. C: Group 3 patients, widespread bilateral lesions.

There was a significant correlation between the extent
of CT involvement and ICU admission. There were 90
patients in group 0 (without radiographic involvement).
Only 2 of them (2.2%) had been transferred to ICU.
Nine patients (5.6%) in group 1 (mild involvement), 12
patients (13.5%) in group 2 (moderate involvement), and
24 patients (17.7) in group 3 (severe involvement) were
transferred to ICU.
There was a significant correlation between the extent
of lung involvement and ICU admission (p < 0.001). The
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results are shown in Table 2. The rate of ICU admission
increased in parallel to the extent of lesions on radiographic
images (Figure 2).
There was a significant correlation between the extent
of CT involvement and mortality. While none of the 90
patients with no imaging findings died, all the 33 patients
who died had radiographic involvement. Moreover, we
found a significant correlation between the extent of
radiographic involvement and mortality. Patients with
more extensive radiographic lesions had a higher mortality
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Table 1. Demographic data’s clinical, radiological, and laboratory values in patients.
n

%

Total

477

ICU –/+

47/430

9.85

Exitus –/+

33/444

6.91

Sex: male/female

262 / 215

54.9/45.1

Symptom duration

No symptom

1 day

2 day

3 day

4 day

n (%)

57 (11.9)

213 (44.7)

156 (32.7)

48 (10.1)

3 (0.6)

Radiological findings
0 (no lesion)

90

18.9

1 (mild)

162

34

2 (moderate)

89

18.7

3 (severe)

136

28.5

n

NV

mean

± SD

median

min- max

Age

49.2

17.8

48

0-92

Symptom duration

1.43

0.85

1

0-4

Laboratory findings
ALT

477

0–50 (U/L)

32.3

27.7

24

3–308

CK

439

0–171 U/L

149.1

297.6

83

8–4001

LDH

454

0–248 (U/L)

261.7

110.3

228

119–1161

CRP

473

0–5 (mg/L)

36

55.4

13.6

0.3–386

Lactate

405

0.5–1.6(mmol/L)

1.7

0.7

1.6

0.5–5.8

D-dimer

449

0–500 (ug/L)

868.7

2684

291

2–34200

Ferritin

447

21–274 (mcg/L)

309.9

479

160

3–4096

Sedimentation

95

5–20 (mm/h)

28.7

26.9

17

2–98

WBC

477

5.6–10.2 (K/uL)

6.26

2.4

5.7

2.3–22

Hemoglobuline

477

12.2–18.1(g/dL)

13.5

1.5

13.7

7.8–17

PLT

477

142–424 (K/uL)

195.3

69.4

183

22–663

Lymphocyte

477

0.6–3.4 (K/uL)

1.60

0.76

1.48

0.25–5.36

Abbreviations: NV: normal values; ALT: alanine aminotransferase; CK: creatinine kinase; LDH: lactate dehydrogenase; CRP:
C-reactive protein; WBC: white blood cell; PLT: platelet count.

rate. The mortality rates were 0% for group 0 (no lesion),
3.8% for group 1 (mild), 12.3% for group 2 (moderate), and
12.5% for group 3 (severe). The difference was significant
(p < 0.001). The results are shown in Table 3 and Figure 2.
The groups were also compared in terms of laboratory
parameters. D-dimer, ferritin, LDH, CRP, ALT, CK, and
sedimentation were significantly higher, and lymphocyte
values were significantly lower in group 2 and group
3. The results are shown in Table 4. As the degree of
lung involvement increased, LDH, CRP, D-dimer, and
ferritin values also increased, and lymphocyte values also
decreased (Figure 3). There was no significant difference in
lactate, WBC, and Hg levels.

4. Discussion
Predicting the patients of who will require ICU admission
and have higher mortality rates are of major importance in
the battle against Covid-19. Because, during the pandemic,
appropriately deploying health care resources and
optimizing the utilization of the limited number of ICU
beds and medical devices, such as ventilators, has become
critical for the successful management of this condition.
For this purpose, many studies have been conducted
investigating the prognostic factors of severe disease
and mortality in Covid-19. As a result of these studies
for mortality associated with Covid-19; age, sex (male),
comorbidities (such as obesity, cardiovascular disease,

1015

AYDEMİR et al. / Turk J Med Sci
Table 2. Relationship between the extent of lesions on
radiographic images and need for ICU.
No need
for ICU

Need for
ICU (%)

Absent n: 90

88

2 (2.2)

Present n: 387

342

45 (11.6)

p-value

CT lesion
0.005*

Extensiveness of CT lesions
0 (no lesion) n: 90

88

2 (2.2)

1 (mild) n: 162

153

9 (5.6)

2 (moderate) n: 89

77

12 (13.5)

3 (severe) n: 136

112

24 (17.7)

<0.001**

*Chi-square test was used,
** The Shapiro–Wilk test was used for normality and the
Kruskal–Wallis Test was used for comparison of groups.

diabetes, hypertension, COPD, malignancy, and chronic
kidney disease), height of inflammatory markers such as
interleukin-6, CRP, and ESR, higher blood coagulation
measurements such as D-dimer and ferritin, liver and renal
function disorders such as bilirubin, ALT, and blood urea
nitrogen elevation, higher WBC count and lower absolute
lymphocyte count were defined as prognostic factors [8,9].
We know that, during the follow-up of the patients,
impairment in the above-mentioned laboratory tests and
radiological progression indicate that the disease is getting
worse. Beyond what is known, in our study, unlike other
studies, we investigated the relationship between the
extent of lung involvement not during the follow-up of
the patients, but during the first admission CT scans, and
Mortality (%)

mortality and progression rate. In our study, we found that
scoring the thorax CT taken on the first day of admission
is quite important in showing mortality and intensive care
transfer rate. There was a significant correlation between
the extent of radiographic involvement and mortality rate.
All 33 patients who died had moderate or severe lung
involvement findings on their CT scans and all patients
in the group 0 (no lesions) survived. As the extent and
number of lesions increased, mortality rates increased
significantly. We also found a significant relationship with
the ICU transfer rate. Similarly, 45 of 47 patients with
severe disease progression requiring ICU admission had
lung involvement at first admission day. As the size and
number of the lesions increased, the ICU transfer rates
increased significantly. The results of this study suggest
that patients with extensive lung involvement at baseline
may need close clinical monitoring and admission to the
intensive care unit and have a higher mortality rate.
In this study, all patients who met the diagnostic
criteria for a potential case were tested with PCR and had
a chest CT scan performed at the baseline. Among 477
consecutive patients who tested positive with PCR, 287
had lesions suggestive of Covid-19 on their CT scans.
The pulmonary involvement rate in our cohort was 81%.
Among patients with lesions on radiographic images, 42%
had mild, 13% had moderate, and 35% had severe lung
involvement.
The clinical presentation of patients with Covid-19
varies broadly from asymptomatic cases to patients with
severe respiratory failure who need mechanical ventilatory
support. The gold standard in the diagnosis of this
condition is demonstrating viral RNA using nucleic acid
amplification tests (NAAT). The sensitivity of NAAT used
to diagnose Covid-19, however, also falls short of meeting
expectations. Only 60% of potential Covid-19 patients
ICU Transfer (%)

20
18
16
14
12
10
8
6
4
2
0

GRUP 0 (n:90)

GRUP 1 (n:162)

GRUP 2 (n:89)

GRUP 3 (n:136)

Figure 2. Mortality and ICU transfer rates according to radiological groups.
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Table 3. Relationship between the extent of lesions on
radiographic images and mortality.
Survival

Nonsurvival (%)

Absent n: 90

90

-

Present n: 387

354

33 (8.5)

p-value

CT lesion
0.001*

Extensiveness of CT lesions
0 (no lesion) n: 90

90

-

1 (mild) n: 162

157

5 (3.08)

2 (moderate) n: 89

78

11 (12.35)

3 (severe) n: 136

119

17 (12.5)

<0.001**

*Chi-square test was used,
**The Shapiro–Wilk test was used for normality and the Kruskal–
Wallis Test was used for comparison of groups.

with clinical, radiographic, and laboratory findings test
positive with PCR [6,10]. A significant proportion of
patients who repeatedly test negative with PCR have
positive antibody test results later on, which reinforces the
perception that PCR test is not reliable in the diagnosis of
Covid-19 [10,11].
This shortcoming of the PCR test has resulted in
the common use of chest CT scans in the diagnosis of
Covid-19 and when deciding to start the treatment for it.
Based on the literature reports, chest CT has a diagnostic
value of more than 90% and is more reliable than a PCR
test. In the great majority of moderate-to-severe Covid-19
patients who require hospitalization, the most significant

presentation is pneumonia. The typical chest CT findings
for Covid-19 include ground-glass opacities, consolidation,
and cobblestone appearance. In a 919-patient series
reported by Sana et al., 88% of the patients had groundglass appearance and 31% had consolidation. Lesion
distribution was reported as bilateral in 87%, multilobar
in 79%, and peripheral in 76% of the cases [7]. Typical
imaging findings of Covid-19 have been well-described,
which improves the diagnostic value of the CT scan [12].
In a cohort of 1014 patients, the correlation between CT
scans and PCR test was investigated, and the sensitivity
of the CT was reported as 97%. Based on these reports,
chest CT is commonly and reliably used in the diagnosis
of Covid-19 and when deciding to introduce treatment for
it. In addition to the role of chest CT in the diagnosis and
treatment decisions, this study demonstrates that a simple
scoring system may help to predict the disease progression.
Based on estimates from three major cohorts, 30%–
40% of Covid-19 patients are asymptomatic. In the
cruise ship Diamond Princess, 41% of the patients were
asymptomatic at baseline and remained free of symptoms
for the entire duration of the observation period. Imaging
findings were observed in 52% of the asymptomatic cases,
and 7% of those who progressed to a disease severity
which required oxygen support. Based on reports from a
study that reviewed 3200 Covid-19 patients who died in
Italy, 5.7% of the patients were asymptomatic when they
first presented to the hospital. The available data suggests
that clinical symptoms at baseline fall short of predicting
progression and mortality in severe disease. In previous
reviews, a clear relationship was not found between death
in Covid-19 patients and the presence of clinical symptoms
[8,9].

Table 4. Comparison of laboratory parameters according to radiological groups.
GROUP 0
No pneumonia
group n: 90

GROUP 1
Mild pneumonia
group n: 162

GROUP 2
GROUP 3
p-value p-value p-value p-value
Moderate pneumonia Severe pneumonia
0 vs 3
1vs 3
2 vs 3
0 vs 1
group n: 89
group n: 136

Age

37.86

44.76

52.66

59.72

<0.001

<0.001

0.001

<0.001

ALT

22.36

32.81

34.31

36.93

<0.001

0.03

0.544

<0.001

CK

90.43

132.01

174.16

189.23

<0.001

0.019

0.292

0.081

LDH

195.8

234.06

233.7

331.85

<0.001

<0.001

<0.001

<0.001

CRP

12.32

16.78

42.73

70.25

<0.001

<0.001

<0.001

<0.001

D-dimer

274.3

510.5

1176.5

1000.9

<0.001

<0.001

0.069

0.013

Ferritin

120.1

182.8

315

551.4

<0.001

<0.001

<0.001

0.002

Sedim

17.45

20.1

45.47

60.69

0.001

0.003

0.16

0.038

Lymph

1.83

1.74

1.44

1.41

<0.001

<0.001

0.367

0.292

The Shapiro–Wilk test was used for normality and the Mann–Whitney U test was used for comparison of groups.
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Age
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CRP
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LDH
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800
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400
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0
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(n:136)

Ly m p ho c i t e
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1.50
1.00
0.50
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(n:90)
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(n:162)
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(n:89)
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(n:136)
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Grup 0
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(n:89)

Grup 3
(n:136)

Figure 3. Laboratory values according to radiological groups.

The extent of radiographic involvement may prove to
be useful in this situation.
In this study, we also evaluated the correlation
between the extent of radiographic involvement and
certain laboratory parameters. A standard test panel was
created based on available Covid-19 data and a significant
correlation was determined between the D-dimer, ferritin,
LDH, CRP, ALT, CK, lymphocyte, and sedimentation at
baseline and the extent of radiographic involvement. In
addition to the presence of radiographic involvement, the
extent of the involvement also showed a strong correlation.
LDH had the strongest correlation with the extent of lung
involvement, with LDH levels increasing in parallel to
the extent of involvement and distinct differences were
observed between the four patient groups. D-dimer, CRP,
and ferritin levels also increased in proportion to the
extent of lesions and significant differences were identified
in three of the four groups. In addition to the correlation
between increased levels of ferritin, D-dimer, CRP, and
low lymphocyte counts and ICU admission and mortality
reported by previous studies, this study showed that the
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extent of radiographic involvement is also related to
laboratory values.
This result further reinforces the importance of the
extent of radiographic involvement in first admission.
The key strength of this study is that all radiographic and
laboratory tests were performed concurrently at baseline.
It is a known fact that D-dimer, CRP, and ferritin levels
increase and lymphocyte count decreases as the disease
progresses and there is also radiographic progression.
Our study was built on whether the radiological size and
number score we obtained on the first day could predict
the progression of patients, their going to ICU, and
mortality. Our results suggest that based on data obtained
at initial admission presentation, it is possible to predict
which patients may progress.
The strength of our study is that it is the first study on this
area, as far as we know. Our study has some limitations. To
what extent accounting for these radiological factors will
improve clinically important outcomes is a question that
cannot be addressed with our results. In addition, there
are multiple individual prognostic factors for outcome

AYDEMİR et al. / Turk J Med Sci
prediction and this is a limitation of our study. Multivariable
models provide a solution to this limitation; our work can also
provide solid grounds for development of these prognostic
tools. For example, they could select a set of prognostic
factors for which there is high certainty in a significant
risk incremental increase (e.g., age, sex, comorbidities,
respiratory failure, impaired certain laboratory tests, and
extent of radiological involvement) and use them to define
hospitalization rules for patients consulting to the emergency
department. The second limitation of this study is that
patient symptoms could not be included in the evaluation
because the records were found to be unreliable. Thus, the
correlation between the extent of radiographic involvement
and patient symptoms could not be evaluated. However, the
time elapsed between the onset of symptoms and the first
presentation was evaluated because patients’ first admission
to the hospital and the onset of symptoms may be different
for each patient, and this difference is important in terms of
disease stage. Radiological involvement can change in every
stage of the disease. In our study, the average duration of
symptoms was 1.43 days, and 89% of the patients applied
within the first 2 days. The shortness of this period can be
explained as the very high awareness in the society because
our study was conducted in the very early stages of the
pandemic. Therefore, there were no late-stage patients in our
patient population, and this did not affect our results.
In conclusion, we were able to demonstrate a strong
correlation between the extent of radiographic involvement
at baseline and the need for ICU admission, mortality rates,
and laboratory parameters. Our results may be helpful

in predicting which patients are at greater risk of disease
progression and thus may significantly contribute to
improving the success of the health care system in managing
this pandemic. In this way, patients who can be transferred
to the intensive care unit can be followed more carefully and
more closely. For example, some wards can be designed as
first-stage intensive care with supplement of monitors and
patients who are likely to progress can be followed in these
departments.
In this respect, we believe that the results of our study
can benefit enabling patients to access advanced treatments
earlier and ICU bed management.
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